Blood protein may hold key to stopping tumor growth in cancer patients

April 01, 2009

WINSTON-SALEM, N.C. - A recent discovery by researchers at Wake Forest University School of Medicine could clear the way for a new drug that inhibits tumor growth in cancer patients and could potentially help in the healing of wounds.

The discovery stems from a study, recently published in the Proceedings of the National Academy of Sciences of the United States of America, in which researchers looked at angiogenesis - the body's formation of new blood vessels from existing blood vessels - and how some blood proteins are involved in that process and affect blood vessel growth.

Researchers found that a protein called ferritin binds to and cripples the ability of another blood protein, called HKa, to shut down blood vessel growth. Because new blood vessels supply a steady stream of nutrients and oxygen that are essential for tumor growth, researchers found that the binding of the two proteins actually assists in new blood vessel formation by removing HKa's influence and therefore promotes tumor growth.

The finding led researchers to the hypothesis that if they can somehow prevent the binding of ferritin and HKa, it will allow HKa to prevent new blood vessel growth and therefore block the growth of tumors.

The finding also has possible implications for wound care. In order to heal, wounds need blood vessel growth. It is therefore possible that by increasing the binding of ferritin to HKa, one could increase the rate at which a serious wound heals.

"It's been known for a long time that levels of ferritin are increased in people with tumors, but it's never been understood why that happens," said Suzy V. Torti, Ph.D., the study's lead investigator, an associate professor of biochemistry and an expert in iron biology at the School of Medicine. "Ferritin appears to play an important role in blood vessel formation. Further, the interaction between ferritin and HKa may represent a new area of interest for possible drug development."

For the study, researchers injected mice with prostate cancer cells to determine how ferritin and HKa affected the formation of new blood vessels.

The mice injected with the cancer cells grew tumors. But when researchers mixed HKa with the tumor cells, the HKa inhibited blood vessel formation. When researchers added ferritin to the mixture of HKa and cancer cells, however, the ferritin restored blood vessel formation, allowing the tumors to grow again.

"Blood vessels can either be helpful, for example in wound healing, or they can be harmful, for example by favoring tumor growth," Torti said. "Our new finding is that the interaction between ferritin and HKa can influence blood vessel formation. This finding could serve as the basis for strategies to either inhibit or stimulate blood vessels. This opens up a new realm of potential ways to treat tumors or other conditions that depend on new blood vessel formation."

The research team, supported by a National Institutes of Health grant, has begun work to develop an anti-tumor drug based on their findings.

Lan G. Coffman, Ph.D., Derek Parsonage, Ph.D., Ralph D'Agostino Jr., Ph.D., and Frank M. Torti, M.D., M.P.H, all of the Wake Forest University School of Medicine, also collaborated on the study.

Wake Forest University Baptist Medical Center

Cancer Immunotherapy: Immune Suppression and Tumor Growth
by George C. Prendergast (Editor), Elizabeth M. Jaffee (Editor)

There has been major growth in understanding immune suppression mechanisms and its relationship to cancer progression and therapy. This book highlights emerging new principles of immune suppression that drive cancer and it offers radically new ideas about how therapy can be improved by attacking these principles. Following work that firmly establishes immune escape as an essential trait of cancer, recent studies have now defined specific mechanisms of tumoral immune suppression. It also demonstrates how attacking tumors with molecular targeted therapeutics or traditional chemotherapeutic drugs can produce potent anti-tumor effects in preclinical models. This book provides basic, translational, and clinical cancer researchers an indispensable overview of immune escape as a critical trait...

Membranes In Tumor Growth (Developments in Cancer Research)
by Galleotti (Author)

Regulation of Gene Expression in the Tumor Environment: Regulation of melanoma progression by the microenvironment: the roles of PAR-1 and PAFR (The Tumor Microenvironment)
by Menashe Bar-Eli (Editor)

It is now becoming very clear that the development and progression of tumor towards the malignant (metastatic) phenotype depends tightly on the interaction between the tumor cells and the tumor microenvironment. Tumor cells respond to stimuli generated within the tumor microenvironment for their growth advantage while the tumor cell themselves reshape and remodel the architecture and function of their extracellular matrices. The term tumor microenvironment is a wide umbrella consisting of stromal cells such as fibroblasts and endothelial cells and infiltration immune cells including T and B cells, macrophages, and other inflammatory cells (PMNs). These different components of the tumor microenvironment could have stimulatory and inhibitory effects on tumor progression by regulating the...

Growth Regulation of Thyroid Gland and Thyroid Tumors (Frontiers of Hormone Research)
by P. E. Goretzki (Author), H. D. Roher (Editor)

Egf Receptor in Tumor Growth and Progression (Ernst Schering Research Foundation Workshop, 19)
by R. B. Lichtner (Editor), R. N. Harkins (Editor)

The tyrosine kinases are frequently implicated in experimental as well as in human cancer. The best-studied receptor signaling system from this family is the EGF receptor. Experts in this area report on the involvement of the receptor in a variety of human tumors, outline underlying molecular mechanisms for aberrant receptor signaling in experimental systems and present the status of current therapies. A detailed analysis of EGF receptor signal transduction via expression of receptor, ligands, phosphatases and presence of other members of the receptor family will provide new information for the design of therapeutic modalities targeting this receptor system.

Growth Factors and Tumor Promotion: Implications for Risk Assessment
by R. Michael McClain (Editor), Thomas J. Slaga (Editor), Robert Le Boeuf (Editor), Henry C. Pitot (Editor)

Progress in Clinical and Biological Research, Volume 391 Growth Factors and Tumor Promotion Implications for Risk Assessment R. Michael McClain, Thomas J. Slaga, Robert LeBoeuf, and Henry Pitot, Editors Understanding the biological, cellular, and molecular mechanisms of growth factors in carcinogenesis is essential to predicting tumor development both in research and clinical settings. An up-to-date and much needed overview of this field, Growth Factors and Tumor Promotion: Implications for Risk Assessment presents cutting-edge work from scientists involved in all areas of oncology and cancer biology. The book presents 32 chapters exploring a wide range of specialized topics in this field. Material in the text ranges from the biological changes caused by growth factors to quantifying...

Influence of Tumor Development on the Host (Cancer Growth and Progression)
by L.A. Liotta (Editor)

X

Influence of the Host on Tumor Development (Cancer Growth and Progression)
by Ronald B. Herberman (Editor)

X

Role of Prostate-Specific Antigen (PSA) in Pathological Angiogenesis and Prostate Tumor Growth (Cancer Etiology, Diagnosis and Treatments)
by Ravikumar Aalinkeel (Author), Stanley A. Schwartz (Author), B. Bindukumar (Author), Gary J. Smith (Author), Kailash C. Chadha (Author)

Prostate specific antigen (PSA) is a serine protease present in an enzymatically inactive form in human serum at a concentration of nanograms/ml; serum PSA (S-PSA) is used widely as a surrogate marker in the diagnosis and management of prostate cancer (CaP). However, the vast majority of PSA produced in the prostate is secreted as active enzyme into the seminal fluid or is sequestered within the prostate tissue microenvironment. This book examines the role of the prostate-specific antigen in prostate tumour growth.

Tumor Biology: Regulation of Cell Growth, Differentiation and Genetics in Cancer (NATO ASI Series / Cell Biology)
by Asterios S. Tsiftsoglou (Editor), Alan C. Sartorelli (Editor), David E. Housman (Editor), T. Michael Dexter (Editor)

This book provides both basic aspects and the latest findings in the molecular and cellular biology of malignant tumors. The focus is on the mechanisms by which normal and neoplastic cells proliferate, differentiate and undergo apoptosis. The differentiation of hemopoietic, epithelial and neuronal cells is treated with respect to growth factors, signal transduction, transcription factors, and genes regulating the cell cycle and the commitment to maturation. The role of oncogenes in neoplastic cell growth and cell death is also covered. The book deals with the regulation of globin gene expression by the LCR locus and the mechanisms of RNA stability for iron-binding and other proteins. The induction of differentiation of neoplastic cells as an alternative approach to cancer therapy is...